SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $266,579 | -23.3% | 76,824 | +2.8% | 0.00% | – |
Q2 2023 | $347,397 | +4.6% | 74,709 | +4.2% | 0.00% | – |
Q1 2023 | $332,000 | +21785.3% | 71,669 | -61.8% | 0.00% | – |
Q4 2022 | $1,517 | -99.8% | 187,778 | +20.7% | 0.00% | – |
Q3 2022 | $864,000 | +6.0% | 155,577 | -0.5% | 0.00% | – |
Q2 2022 | $815,000 | -41.9% | 156,431 | -8.4% | 0.00% | – |
Q1 2022 | $1,403,000 | +67.8% | 170,766 | +204.1% | 0.00% | – |
Q4 2021 | $836,000 | -21.9% | 56,156 | -1.0% | 0.00% | – |
Q3 2021 | $1,071,000 | -8.8% | 56,719 | -10.2% | 0.00% | – |
Q2 2021 | $1,174,000 | -12.7% | 63,148 | +6.9% | 0.00% | – |
Q1 2021 | $1,345,000 | -7.0% | 59,087 | -11.3% | 0.00% | – |
Q4 2020 | $1,447,000 | +94.2% | 66,597 | -8.0% | 0.00% | – |
Q3 2020 | $745,000 | +16.4% | 72,412 | -12.2% | 0.00% | – |
Q2 2020 | $640,000 | -38.3% | 82,472 | -19.0% | 0.00% | – |
Q1 2020 | $1,038,000 | -8.8% | 101,873 | -1.5% | 0.00% | – |
Q4 2019 | $1,138,000 | +27.0% | 103,418 | +4.9% | 0.00% | – |
Q3 2019 | $896,000 | -16.9% | 98,542 | +3.7% | 0.00% | – |
Q2 2019 | $1,078,000 | -1.3% | 95,039 | -0.9% | 0.00% | – |
Q1 2019 | $1,092,000 | +21.6% | 95,860 | -3.6% | 0.00% | – |
Q4 2018 | $898,000 | -40.2% | 99,451 | -0.6% | 0.00% | – |
Q3 2018 | $1,501,000 | – | 100,050 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |